These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26673877)

  • 21. Neuromyelitis optica and asian phenotype of multiple sclerosis.
    Kira J
    Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
    Misu T; Takano R; Fujihara K; Takahashi T; Sato S; Itoyama Y
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):575-7. PubMed ID: 19372295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
    Juryńczyk M; Craner M; Palace J
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.
    Guo Y; Weigand SD; Popescu BF; Lennon VA; Parisi JE; Pittock SJ; Parks NE; Clardy SL; Howe CL; Lucchinetti CF
    Acta Neuropathol; 2017 Apr; 133(4):597-612. PubMed ID: 28184993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromyelitis optica: concept, immunology and treatment.
    Uzawa A; Mori M; Kuwabara S
    J Clin Neurosci; 2014 Jan; 21(1):12-21. PubMed ID: 23916471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
    Oji S; Nicolussi EM; Kaufmann N; Zeka B; Schanda K; Fujihara K; Illes Z; Dahle C; Reindl M; Lassmann H; Bradl M
    PLoS One; 2016; 11(3):e0151244. PubMed ID: 26990978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
    Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular pathology of multiple sclerosis and neuromyelitis optica].
    Masaki K
    Nihon Rinsho; 2014 Nov; 72(11):1909-17. PubMed ID: 25518370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromyelitis optica-like pathology is dependent on type I interferon response.
    Khorooshi R; Wlodarczyk A; Asgari N; Owens T
    Exp Neurol; 2013 Sep; 247():744-7. PubMed ID: 23434493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
    Popescu BF; Lucchinetti CF
    Handb Clin Neurol; 2016; 133():95-106. PubMed ID: 27112673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
    Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
    J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association of
    Yang TT; He Y; Xiang YJ; Ao DH; Wang YY; Zhang Q; He XJ; Zhong SS; Wu J; Liu GZ
    Transl Neurosci; 2016; 7(1):76-83. PubMed ID: 28123825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biomarkers in neuromyelitis optica].
    Misu T; Takahashi T; Nakashima I; Fujihara K
    Brain Nerve; 2012 May; 64(5):525-35. PubMed ID: 22570066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter.
    Sinclair C; Kirk J; Herron B; Fitzgerald U; McQuaid S
    Acta Neuropathol; 2007 Feb; 113(2):187-94. PubMed ID: 17143632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.